<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">J Neurol Surg B Skull Base</journal-id><journal-id journal-id-type="iso-abbrev">J Neurol Surg B Skull Base</journal-id><journal-id journal-id-type="pmc-domain-id">1844</journal-id><journal-id journal-id-type="pmc-domain">jneurosurg</journal-id><journal-title-group><journal-title>Journal of Neurological Surgery. Part B, Skull Base</journal-title></journal-title-group><issn pub-type="ppub">2193-6331</issn><issn pub-type="epub">2193-634X</issn><publisher><publisher-name>Thieme Medical Publishers</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10171934</article-id><article-id pub-id-type="pmcid-ver">PMC10171934.1</article-id><article-id pub-id-type="pmcaid">10171934</article-id><article-id pub-id-type="pmcaiid">10171934</article-id><article-id pub-id-type="pmid">37187476</article-id><article-id pub-id-type="doi">10.1055/a-1808-1445</article-id><article-id pub-id-type="publisher-id">210218</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Pituitary Adenomas as a Barometer for Health Care Access</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-5954-0613</contrib-id><name name-style="western"><surname>Wallace</surname><given-names initials="NJ">Nathan John</given-names></name><xref rid="AF210218-1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Palmer</surname><given-names initials="WJ">William Jackson</given-names></name><xref rid="AF210218-1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-4375-0421</contrib-id><name name-style="western"><surname>Devaiah</surname><given-names initials="AK">Anand K.</given-names></name><xref rid="AF210218-2" ref-type="aff">2</xref><xref rid="CO210218-1" ref-type="author-notes"/></contrib></contrib-group><aff id="AF210218-1"><label>1</label><institution>Boston University School of Medicine, Boston, Massachusetts, United States</institution></aff><aff id="AF210218-2"><label>2</label><institution>Departments of Otolaryngology, Neurological Surgery, and Ophthalmology, Boston University School of Medicine, Boston, Massachusetts, United States</institution></aff><author-notes><corresp id="CO210218-1"><bold>Address for correspondence </bold>Anand K. Devaiah, MD, FACS <institution>Department of Otolaryngology, Boston Medical Center</institution><addr-line>
800 Harrison Ave, BCD Building, 5
<sup>th</sup>
Floor, Boston, MA 02118
</addr-line><country>United States</country><email>anand.devaiah@bmc.org</email></corresp><fn fn-type="COI-statement" id="d34e149"><p><bold>Conflict of Interest</bold> None declared.</p></fn></author-notes><pub-date pub-type="epub"><day>16</day><month>5</month><year>2022</year></pub-date><pub-date pub-type="collection"><month>6</month><year>2023</year></pub-date><volume>84</volume><issue>3</issue><issue-id pub-id-type="pmc-issue-id">435492</issue-id><fpage>248</fpage><lpage>254</lpage><history><date date-type="received"><day>29</day><month>9</month><year>2021</year></date><date date-type="accepted"><day>18</day><month>3</month><year>2022</year></date></history><pub-history><event event-type="pmc-release"><date><day>16</day><month>05</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>16</day><month>05</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2023-05-16 16:25:31.443"><day>16</day><month>05</month><year>2023</year></date></event></pub-history><permissions><copyright-statement>Thieme. All rights reserved.</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Georg Thieme Verlag KG</copyright-holder></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="10-1055-a-1808-1445.pdf"/><abstract><p><bold>Introduction</bold>
&#8195;Expanding access to care has been shown to impact patient care and disease epidemiology for different disease states, but has not been studied in pituitary adenoma. We hypothesize that increasing access to care&#8212;which includes diagnostics&#8212;through the Affordable Care Act (ACA) and Medicaid expansion has increased identification of pituitary adenomas.
</p><p><bold>Methods</bold>
&#8195;The National Cancer Institute's Surveillance, Epidemiology, and End Results database was utilized to identify patients with pituitary adenomas from 2007&#8211;to 2016 yielding 39,120 cases. Demographic, histologic, and insurance data were extracted. After stratification based on their insurance status, they were plotted to examine trends in insurance status after introduction of the ACA and Medicaid expansion.
</p><p>Magnetic resonance imaging (MRI) data was gathered from the Organization for Economic Co-operation and Development. A linear regression model was developed to describe the relationship between pituitary adenoma discovery and the number of MRI exams.</p><p><bold>Results</bold>
&#8195;Pituitary adenoma diagnoses (37.6%) and MRI examinations per 1,000 in the U.S. (32.3%) increased concurrently from 2007 to 2016. Linear regression analysis revealed a statistically significant relationship (
<italic toggle="yes">p</italic>
&#8201;=&#8201;0.0004). Those patients without insurance diagnosed with pituitary adenomas decreased 36.8% after Medicaid expansion (
<italic toggle="yes">p</italic>
&#8201;=&#8201;0.023). With respect to Medicaid utilization, significant increases of 28.5% (
<italic toggle="yes">p</italic>
&#8201;=&#8201;0.014) and 30.3% (
<italic toggle="yes">p</italic>
&#8201;=&#8201;0.00096) were noted after both the ACA enactment and Medicaid expansion, respectively.
</p><p><bold>Conclusion</bold>
&#8195;The ACA has expanded health care access which has increased the ability to identify patients with pituitary adenomas. The present study also provides evidence that access to care is important for less prevalent diseases such as pituitary adenomas.
</p></abstract><kwd-group><title>Keywords</title><kwd>pituitary adenoma</kwd><kwd>health care disparities</kwd><kwd>Affordable Care Act</kwd><kwd>MRI</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>